Search

everythinglearnresearchcommunity

for

Search:↓

The consensus provides guidelines for safely stopping danazol in hereditary angioedema treatment.

A personalized treatment combining traditional and new therapies may improve hair loss outcomes in alopecia areata.

New medications could improve treatment for severe alopecia areata in Australia.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

IGF-1 can help regrow hair and may be a promising treatment for hair loss.

Hangeshashinto's natural products may help treat stomatitis by reducing inflammation and cytotoxicity.

International guidelines for treating alopecia areata vary, focusing on different treatment options and related health issues.

Phenol is effective for skin treatments but poses serious health risks and must be used cautiously by trained doctors.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Advancements in diagnostics, treatments, and technology have improved hair loss detection and restoration, with some types being reversible.

People with primary scarring alopecia have higher risks of other health issues like vitamin D deficiency and thyroid disease.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

PCA patients have more harmful bacteria and antibiotic resistance, needing specific testing for treatment.

Extracellular vesicles show promise for treating psoriasis by reducing inflammation and skin lesions.

Topical treatments like minoxidil and corticosteroids are effective for hair loss, with JAK inhibitors promising for alopecia areata.

New regenerative therapies show promise for treating hair loss.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

A COVID-19 infected patient with chronic kidney disease experienced worsened kidney function, hair loss, and unexpected wart clearance.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

AKN is a chronic scalp condition in African-descended males, treated with topicals, antibiotics, steroids, and sometimes surgery or laser.

Certain hairstyles, diabetes, scalp infections, and vitamin D deficiency may increase the risk of hair loss in Black women; more research is needed for better treatment.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Alopecia Areata is linked to a higher risk of several diseases, which vary with age and sex.

New understanding and treatments for hair loss are improving, but more research is needed.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.